TED · Unknown
Amphotericin (Ambisome®).
A public procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland "NSS") via TED.
TEDUnknown
- —
- Award value
- £7.6m
- Tender value
- 0
- Suppliers
- 0
- Awards
- 1
- Notices
- Unknown
- Stage
Key details
- Source
- TED
- Lifecycle stage
- Unknown
- Status
- —
- CPV classification
- 33690000
- Currency
- GBP
- Total award value
- —
- Tender value
- £7,620,379
- First published
- 3 Aug 2017
- Last updated
- 3 Aug 2017
Notice timeline
Every published notice in this procurement's lifecycle.
Frameworks & programmes
More from The Common Services Agency (more commonly known as NHS National Services Scotland "NSS")
Growth Hormone
Tender · TEDGreater Glasgow Health Board Radiotherapy OMS, TPS and DICOM Archive
Unknown · TEDGrampian Health Board Radiotherapy Linac, R&V and TPS
Unknown · TEDHepatitis B Immunoglobulin Intramuscular Use (IM)
Unknown · TEDAnti Rabies Immunoglobulin Intramuscular Use (IM)
Unknown · TEDTetanus Immunoglobulin Intramuscular Use (IM)
Unknown · TEDFAQs about this procurement
Who is the buyer for "Amphotericin (Ambisome®)."?
Amphotericin (Ambisome®). is a UK public-sector procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland "NSS") via TED.
Has "Amphotericin (Ambisome®)." been awarded?
No award has been recorded yet. The current lifecycle stage is "Unknown".
What is "Amphotericin (Ambisome®)." worth?
The reported tender value is £7,620,379.
When was "Amphotericin (Ambisome®)." published?
It was first published on 3 Aug 2017 and last updated on 3 Aug 2017, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable